Educational resources

This section includes resources developed by Guidelines, including algorithms, medicines appraisal cards, supplements, and videos. Items may contain pharmaceutical promotional information.

Videos

Updates in best practice management of venous thromboembolism

Commissioned by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance

These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100782 | Date of preparation: September 2021

Modern management of stroke prevention in non-valvular atrial fibrillation

Commissioned by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance

GOLD COPD 2021 summary tour

By Guidelines team

This Guidelines summary tour highlights the new recommendations in the GOLD 2021 report, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease

The holistic management of patients requiring anticoagulation

Commissioned by Bayer plc

This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021

Non-alcoholic steatohepatitis: identification, management, and referral pathways

Commissioned by Intercept Pharma UK and Ireland Ltd

The content on this page is intended for UK healthcare professionals only.

Identification of pancreatic exocrine insufficiency (PEI) in patients with diabetes

Commissioned by Viatris

In this video, Su Down looks at the identification of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3287 December 2020

Assessment of pancreatic exocrine insufficiency (PEI) in primary care

Commissioned by Viatris

In this video, Professor Michael Cummings looks at the assessment of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3288 December 2020

Management of pancreatic exocrine insufficiency (PEI) in primary care

Commissioned by Viatris

In this video, Professor Michael Cummings looks at the management of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3289 December 2020

Management of common eye conditions: blepharitis

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) explains the symptoms and management of blepharitis.

Management of common eye conditions: conjunctivitis

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) describes the causes, symptoms, and treatment of conjunctivitis.

Webinars

Half-day virtual event focusing on practical approaches to management of gastrointestinal disorders and iron deficiency

Commissioned by Norgine Pharmaceuticals Limited

Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines.
UK-COR-NP-2100043
Date of preparation: July 2021

Cancer support that complements your care - Macmillan’s Support Line can help your patients.

This is promotional material from Macmillan Cancer Support.

Our specialist advisers on the Macmillan Support Line can answer your patients’ questions after and in between appointments, or simply be there when they need a listening ear. Learn more here.

Medicines appraisal cards

NICE Technology Appraisal 651: Naldemedine ▼ for treating opioid‑induced constipation

Commissioned by Sandoz Limited

The production and printing of this Guidelines summary card has been commissioned by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information

UK/P/RZM/20-0016c October 2020

Supplements

Recommending emollients for patients with atopic dermatitis or dry skin conditions

Commissioned by L’Oréal (UK) Limited

This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines.
Date of preparation: January 2021

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.

Prescribing summary cards

Soolantra® (ivermectin) 10 mg/g cream

Commissioned by Galderma UK Ltd

This prescribing summary card was developed from content provided by Galderma UK Ltd. Information intended for UK healthcare professionals only.
View Soolantra^® (ivermectin) 10 mg/g cream prescribing and adverse event reporting information.
UKI-SOC-2100031 September 2021

Working party guidelines and algorithms

Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes

By Working party–Down Beba Davies Diggle Goel

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd.

Primary care management of iron deficiency anaemia

Commissioned by Norgine Pharmaceuticals Limited

This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
UK-HAE-FER-2100104
Date of preparation: July 2021

Prescribing combined hormone replacement therapy (HRT) containing dydrogesterone

Commissioned by Viatris

This promotional algorithm has been commissioned and funded by Viatris and developed in partnership with Guidelines. Intended for UK healthcare professionals.
View Femoston^® (estradiol/dydrogesterone) and Femoston^® -conti (estradiol/dydrogesterone) prescribing and adverse event reporting information.
FEM-2021-0238 June 2021

Diabetes and frailty: guidance on the management of older adults with type 2 diabetes

By Strain Down Brown Puttanna and Sinclair

Information intended for UK healthcare professionals only. This summary was developed by Guidelines and Dr Strain, based on the guidance developed by Strain WD et al., with the support of a sponsorship from Novo Nordisk UK.

Managing obesity in primary care

By Development Group—Tahrani Parretti O’Kane Chowhan Ratcliffe and Le Brocq

This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.

Anticholinergics and cognitive impairment in the treatment of overactive bladder

Commissioned by Contura Ltd

This management algorithm has been commissioned and funded by Contura Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals.
View adverse event reporting and prescribing information

REG/2020/224 September 2020

Osteoporotic fracture guideline

By Working party—Cooper Javaid Elliott Stephens Tanna

This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.

Inhaler choice guideline

By Development group—Usmani Capstick Saleem Scullion

This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.

Women of child-bearing age with inflammatory rheumatic diseases guideline

By Working party—Giles Allen Nelson-Piercy Tower Warburton Gordon

This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.

Consensus guideline on the holistic management of patients requiring anticoagulation

By Working party–Fay Antoniou Martins Merriman Patrickson Uprichard

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.

Hosted content

Calculating renal function in patients with atrial fibrillation

Developed and funded by the Bristol Myers Squibb/Pfizer Alliance

This animation has been developed and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals.

432-GB-2100230 June 2021